Jay S. Stout, Chief Technology Officer at Immunovant, Inc. (IMVT), sold 40,000 shares at $38.18 ($1.5M) on 2026-06-26, disclosed to the SEC on 2026-06-26.
Open-market sale of $1.5M IMVT by Chief Technology Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $38.18 | 33,277 | $1.3M | 82.9% |
| 2 | $38.94 | 6,723 | $262K | 17.1% |
| Total | $38.31 avg | 40,000 | $1.5M | 100% |
| Filing → |
| IMVT | SELL | 2026-04-24 | $82K | — | Filing → |
| IMVT | SELL | 2026-04-10 | $252K | — | Filing → |
| IMVT | SELL | 2026-01-23 | $51K | — | Filing → |